Abstract
To the Editor: Onychomycosis is a common nail condition with worldwide prevalence of 3% to 10%.1,2 Oral terbinafine is frequently prescribed because of its efficacy and infrequent adverse events.1 Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) baseline and interval testing are recommended, without supporting evidence.1 Our objectives were to retrospectively analyze the frequency and severity of abnormal laboratory test results in adults without pre-existing hepatic and hematologic conditions prescribed terbinafine for onychomycosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
